Beta Bionics, Inc. Operating Lease Cost
Beta Bionics, Inc. (BBNX) reported Operating Lease Cost of $516.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-07-29
- Beta Bionics, Inc. operating lease, cost for the quarter ending 2026-06-30 was $516.00K, a 23.44% increase year-over-year.
- Beta Bionics, Inc. operating lease, cost for the quarter ending 2026-03-31 was $529.00K, a 27.47% increase year-over-year.
- Beta Bionics, Inc. operating lease, cost for the quarter ending 2025-12-31 was $561.00K, a 36.50% increase year-over-year.
- Beta Bionics, Inc. operating lease, cost for the quarter ending 2025-09-30 was $409.00K, a 28.21% increase year-over-year.
- Beta Bionics, Inc. operating lease, cost for fiscal 2025 was $1.80M, a 31.13% increase from fiscal 2024.
- Beta Bionics, Inc. operating lease, cost for fiscal 2024 was $1.38M, a 36.41% increase from fiscal 2023.
- Beta Bionics, Inc. operating lease, cost for fiscal 2023 was $1.01M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $516.00K 10-Q · filed 2026-07-29 | $1.04M 10-Q · filed 2026-07-29 | $1.61M derived: sum of 3 quarters · filed 2026-07-29 | $2.02M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $529.00K 10-Q · filed 2026-04-21 | $1.09M derived: sum of 2 quarters · filed 2026-04-21 | $1.50M derived: sum of 3 quarters · filed 2026-04-21 | $1.92M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $561.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $970.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.39M derived: sum of 3 quarters · filed 2026-07-29 | $1.80M 10-K · filed 2026-02-24 |
| 2025-09-30 | $409.00K 10-Q · filed 2025-10-28 | $827.00K derived: sum of 2 quarters · filed 2026-07-29 | $1.24M 10-Q · filed 2025-10-28 | $1.65M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $418.00K 10-Q · filed 2026-07-29 | $833.00K 10-Q · filed 2026-07-29 | $1.24M derived: sum of 3 quarters · filed 2026-07-29 | $1.56M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $415.00K 10-Q · filed 2026-04-21 | $826.00K derived: sum of 2 quarters · filed 2026-04-21 | $1.15M derived: sum of 3 quarters · filed 2026-04-21 | $1.47M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $411.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $730.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.05M derived: sum of 3 quarters · filed 2026-02-24 | $1.38M 10-K · filed 2026-02-24 |
| 2024-09-30 | $319.00K 10-Q · filed 2025-10-28 | $640.00K derived: sum of 2 quarters · filed 2025-10-28 | $964.00K 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $321.00K 10-Q · filed 2025-07-29 | $645.00K 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $324.00K 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $1.01M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |